The approval of immune checkpoint inhibitor combination therapy may be the most significant advance in a decade for the treatment of metastatic renal cell carcinoma, an expert says.
Renal Cell Carcinoma
While they may have potential anti-tumor effects in other cancers, non-steroidal anti-inflammatory drugs do not appear to confer a survival benefit in metastatic renal cell carcinoma.
High levels of visceral fat were associated with a significantly increased risk of death in women with clear cell renal cell carcinoma, but not in men, results of a recent retrospective study show.
“The findings should serve as a call to action for urologic specialists who care for patients with cancer,” says Alexander Kutikov, MD.
A recent study suggests experimental "texture analysis" of renal masses via computed tomography scan holds promise as a technique to allow more effective risk stratification.
"In the end, it is up to the surgeons who wish to continue to perform these robotic procedure to demonstrate their cost-effectiveness," writes Badar M. Mian, MD.
An updated guideline on localized kidney cancer as well as a look at active surveillance as initial management for renal masses
Results from a recent prospective trial suggest that active surveillance may be suitable for some patients with advanced renal cell carcinoma.